Wilkins Miller Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$564K Sell
470
-15
-3% -$15.3K 0.31% 58
2026
Q1
$446K Sell
485
-10
-2% -$10.1K 0.27% 62
2025
Q4
$532K Hold
495
0.32% 57
2025
Q3
$378K Sell
495
-17
-3% -$12.7K 0.23% 65
2025
Q2
$399K Hold
512
0.27% 64
2025
Q1
$423K Sell
512
-33
-6% -$27.5K 0.32% 57
2024
Q4
$421K Buy
+545
New +$451K 0.44% 43

Other funds holding LLY

Wilkins Miller Wealth Management's LLY Position: Q2 2026 in Review

Wilkins Miller Wealth Management reduced its Eli Lilly (LLY) stake by 3.1% in Q2 2026, selling an estimated $15.3K and leaving 470 shares worth $564K. The position accounts for 0.31% of the portfolio, ranked #58.

Wilkins Miller Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wilkins Miller Wealth Management held 470 shares of Eli Lilly worth $564K as of Q2 2026.
  • Wilkins Miller Wealth Management sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.31% of Wilkins Miller Wealth Management's portfolio in Q2 2026, its #58 holding.
  • Wilkins Miller Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wilkins Miller Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.